Havana, Cuba

Yuliet Mazola Reyes

This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignees: Centro De Ingenieria Genetica Y Biotechnologia, Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuliet Mazola Reyes. Retrieved from https://idiyas.com/inventor/yuliet-mazola-reyes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • La Habana, CU (2014)
  • Havana, CU (2014)

Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuliet Mazola Reyes: Innovator in Pharmaceutical Chemistry

Introduction

Yuliet Mazola Reyes is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a focus on addressing critical health issues, her work has garnered attention in the scientific community.

Latest Patents

Yuliet holds 2 patents that showcase her expertise in creating novel chemical compounds. Her latest patents include "Antineoplastic compounds and pharmaceutical compositions thereof," which involves chemical compounds derived through in silico molecular modeling. These compounds are designed to block phosphorylation events by interacting specifically with the Casein Kinase 2 enzyme substrate phosphorylation domain. This invention also encompasses pharmaceutical compositions that utilize these compounds for treating diseases related to neoplastic processes. Another significant patent is focused on the "Use of chemical compounds obtained in silico for the preparation of pharmaceutical compositions to attenuate or inhibit Dengue virus infection." This invention aims to modulate various stages of the viral replication cycle, particularly concerning the entry of the virus into host cells and the assembly of mature progeny virions. It also includes the use of these pharmaceutical compositions for both prophylactic and therapeutic treatments against all four serotypes of the Dengue virus and other flaviviruses.

Career Highlights

Yuliet has worked with notable institutions such as the Centro de Ingeniería Genética y Biotecnología, where she has contributed to groundbreaking research in genetic engineering and biotechnology. Her work has been instrumental in advancing the understanding and treatment of various diseases.

Collaborations

Throughout her career, Yuliet has collaborated with esteemed colleagues, including Roberto Vera Alvarez and Alexis Musacchio Lasa. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Yuliet Mazola Reyes stands out as an innovative inventor in the pharmaceutical field, with her patents addressing critical health challenges. Her contributions to the development of antineoplastic compounds and antiviral treatments highlight her commitment to improving medical outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…